glp-1 and ulcerative colitis GLUCAGON-LIKE 1 RECEPTOR AGONIST USE WAS ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LARGE REAL-WORLD DATABASE STUDY The alleviating effect and mechanism
Description
10.2337/DB15-1141 [DOI] [PubMed] [Google Scholar] Clarke S
(available at: [Google Scholar] 69.Athauda D, Gulyani S, Karnati HK, Li Y, Tweedie D, Mustapic M, Chawla S, Chowdhury K, Skene SS, Greig NHet al
Acknowledgments DHVR is supported by a senior fellowship from the Dutch Diabetes Foundation and a senior Kolff Fellowship from the Dutch Kidney Foundation
Improvement of Gastric Emptying in Diabetic Gastroparesis by Erythromycin
